Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodiesErwin De Genst, Karen Silence, Klaas Decanniere, et al.Journal of Molecular Biology|August 13, 2005
Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodiesDirk Saerens, Mireille Pellis, Remy Loris, et al.Nature Medicine|April 11, 2006
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factorToya Nath Baral, Stefan Magez, Benoît Stijlemans, et al.International Journal of Cancer|March 29, 2002
Efficient tumor targeting by single-domain antibody fragments of camelsVirna Cortez-Retamozo, Marc Lauwereys, Gholamreza Hassanzadeh Gh, et al.Molecular Immunology|July 11, 2008
VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'Issam Hmila, Ben Abderrazek-Ben Abdallah R, Dirk Saerens, et al.Protein Science : a Publication of the Protein Society|February 16, 2002
Single-domain antibody fragments with high conformational stabilityMireille Dumoulin, Katja Conrath, Annemie Van Meirhaeghe, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infectionsAngus M MacLeod, Dale R Mitchell, Nicholas J Palmer, et al.Journal of Immunological Methods|November 13, 2007
Parallel selection of multiple anti-infectome Nanobodies without access to purified antigensDirk Saerens, Benoît Stijlemans, Toya Nath Baral, et al.Analytical Chemistry|December 1, 2005
Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensingDirk Saerens, Filip Frederix, Gunter Reekmans, et al.Frontiers in Molecular Biosciences|October 4, 2021
CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple TherapyEyleen de Poel, Sacha Spelier, Ricardo Korporaal, et al.Pageof 5